Archive for the ‘IBM’ Category

IBM’s Watson Makes the Move From Answering Trivia Questions to Making Medical Diagnoses

What is...Toronto (General Hospital)?

When Watson was competing on Jeopardy!, its massive databanks were filled with encyclopedias, novels, film scripts, and history books. These days, Watson is more into medical journals and misspelled Yahoo Answers blog posts about weird rashes and vague abdominal pains. Watson is maturing, and prepping for his first non-trivia, real-world application: medical diagnoses. He's all *sniff* grown up!

We've known medicine was to be the next step for Watson for some time, but just recently, IBM gave a short demonstration of Watson's progress. Watson isn't the first attempt at an automated diagnosis program--we documented Artemis, and Isabel has been around for a few years--but Watson's incredible power, depth of knowledge, and ability to understand natural human language puts it in a totally different league. Diagnosing an ailment isn't really that much different from answering a trivia question; Watson takes in as much information as possible from the question, eliminating the potential answers as new information renders them impossible, and comes up with a list of likely answers. An example from the AP: "As more clues were unveiled - blurred vision, family history of arthritis, Connecticut residence - Watson's suggested diagnoses evolved from uveitis to Behcet's disease to Lyme disease. It gave the final diagnosis a 73 percent confidence rating."

While on Jeopardy!, Watson could only give one answer, but in medicine, it lists all possible answers, along with the percent likeliness. An 80% possibility of accuracy is enough for Watson to risk money on Jeopardy, but when working with possible diagnoses, that still leaves a one in five chance that the patient is afflicted with something else, so Watson is designed to divulge even the less likely answers.

Watson's human language recognition skills also allows it to input an entirely new sector of information: anecdotal evidence. Anecdotal evidence is not necessarily reliable, of course, but can still be extremely useful--it's worth noting that a patient's description of symptoms is anecdotal, and still very important to diagnosis. Watson is able to trawl through the internet, picking up the oodles of medical information out there and adding it to its memory banks. Being able to understand that, say, a "dry mouth" is the same as xerostomia can make legitimate use of all those confused forums.

Of course, Watson isn't designed to replace a doctor's diagnostic instincts. Instead, it's more like a futuristic reference book. There's simply too much information out there these days, in too many places and added too frequently, for any doctor to keep up. Watson could help keep track of all the new drugs, studies, journals, and anecdotal evidence.

Diagnosis systems using Watson are still likely a few years away, but IBM is working on ways to leverage Watson's abilities even to hospitals with budgets too small to afford a multimillion-dollar Watson of their own. iPad apps were mentioned as a distinct possibility--doctors could tap into an off-site Watson with an iPad, shoot off a few queries and receive an answer immediately. And as more medical data is digitized, Watson will only get stronger and more useful.

[Associated Press]

Fresh From Jeopardy, Artificial Intelligence Fights Infection in the ICU

It’s entertaining to watch IBM’s Watson make mincemeat of its human counterparts on Jeopardy, but the computing techniques that helped the computer best humans at trivia could soon be saving lives in the ICU. Artemis, a software program built on the back of IBM analytics software similar to that powering Watson, is being tested as a means to provide early warnings when babies in the ICU acquire hospital-borne infections.

The ICU is naturally an environment fraught with problems, but one of the most fundamental is an information glut--patients there are surrounded by equipment churning out streams of data about each one, yet there’s no way to distill all this data to its relevant meaning in real time (usually it’s broken down into notes by a nurse once an hour).

Meanwhile, all that meaningful data on blood oxygen levels, respiratory rates, heart rates, electrocardiogram, temperature, etc. is basically ignored because there’s no way to monitor everything for patterns or trends that might hide an underlying indicator. That’s what Artemis does. Grabbing data from both medical records and those real time sensors feeding data to the machine, Artemis’ algorithms look for signals that an infection might be taking root.

This is where Artemis begins to compute like Watson. The two are different in several ways, but Artemis was built on an analytics platform called InfoSphere that came out of IBM research just as Watson did. And both make decisions on the fly based on rapidly incoming data from multiple sources, no archiving necessary.

Conventional computers can hunt for trends or patterns in data just fine, but before they can do so the data needs to be written to hard drive and databased. Artemis, like Watson, takes its inputs on go. Information flows in, the software filters out the relevant bits (be they answers to questions or symptoms) and the rest of the data flows on downstream. In a world where data is being produced prodigiously, such a computing paradigm has great potential.

And in an ICU environment, it could be lifesaving. Artemis can handle multiple streams of data from multiple infants, monitoring for the telltale signs of an infection before it gets the chance to take root (it also helps doctors refrain from diagnosing false-positives). It could someday be deployed as a centralized, remote diagnosis system, accepting online data streams from faraway locations and serving ICUs around the world.

As such, Artemis is already going global; two Chinese neonatal ICUs will connect using the technology later this year.

[Technology Review]

Degradable Nanoparticles Search, Intercept and Destroy Antibiotic-Resistant Bacteria

Bludgeoning bacteria instead of drugging it

A new breed of biodegradable nanoparticles can glom on to drug-resistant bacteria, breaching their cell walls and leaking out their contents, selectively killing them. The polymer particles could someday be used in anything from injectable treatments for drug-resistant bacteria, to new antibacterial soaps and deodorants, according to inventors at IBM. After their work is done, the particles break apart, flushing away with the invaders they destroyed.

The nanoparticles, which IBM says are relatively inexpensive, were effective against bugs that have been evolving to resist antibiotics, including methicillin-resistant Staphylococcus aureus (MRSA). Preliminary results suggest the particles could also be effective against yeast, fungus and small bacteria like E. coli, IBM says. Research on the new particles is reported in this week’s issue of the journal Nature Chemistry.

Antibiotics kill microorganisms in various ways, including interfering with their DNA or interacting with their ability to rebuild their cell walls, explains James Hedrick, advanced organic materials scientist and master inventor at IBM Almaden Research Center in San Jose, Calif. But some of the bugs survive the onslaught, leading to new generations of bacteria that won’t succumb to the drugs.

A new class of positively charged plastic micro-machines, including IBM's nanoparticles, take a somewhat more physical approach.

“These are designed to slice the cell membrane, to rip the membrane up and eliminate the contents,” Hedrick said. “It’s kind of like the way a virus would work — a virus drills a pore, empties the contents and hijacks it. This is drilling in little holes, and all the contents leak out.”

Transmission electron micrographs show it works: As the images show, the cell walls have been ruptured and everything inside is gone. The best part is that bacteria cannot evolve resistance because it's a physical attack, not a chemical one.

These particles are special because they self-assemble in water and are biodegradable, unlike other nanoparticle treatments. They’re made of amphiphilic polycarbonate material, meaning some of the particles are water-loving and some are water-phobic. When exposed to fluids — like serum or blood — the polycarbonate self-assembles into clumps about 200 nanometers in size. Another part of the clump is positively charged, designed to match the negatively charged surface of microbes, Hedrick said.

Cell walls are dynamic barriers, constantly morphing and changing as they divide. When something binds to their surface, the walls’ synthesis is interrupted. Penicillin, for instance, binds to an enzyme that helps build the walls. Hedrick and collaborators at the Institute of Bioengineering and Nanotechnology in Singapore say the charged particles interact with the cell walls to destabilize them.

“These particles are cationic (positively charged), so they are attracted to the microbial membrane surface, and it begins to disrupt that dynamic assembly process of the membrane,” Hedrick said.

The authors also report that the particles can be used at relatively low concentrations. Hedrick said they’re not sure what makes the particles so effective, but it’s probably because they can each kill multiple cells, moving on to new targets after the membranes are so disfigured that static no longer binds the cells and nanoparticles together.

“A little of the polymer goes a long way,” Hedrick said.

After a few days of this, enzymes start breaking apart the chains that hold the particles together, said Bob Allen, senior manager at IBM-Almaden’s Advanced Materials Chemistry department.

“Think of the enzyme as a pair of scissors — it will go through and snip it. It’s just a weak link that allows you to have a degradable system,” he said.

The particles degrade to molecules of alcohol and carbon dioxide, which are removed just like anything else in the bloodstream.

IBM believes the particles could be a new way to treat drug-resistant bacteria, especially MRSA, which is frequently associated with hospital infections. The company says antibiotic-resistant bacteria is a fertile field for its polymer research labs — chemists do focus primarily on electronics, but chip-scale research translates well to research in health care, water purification, and energy, Allen said.

Hedrick and Allen cautioned that they’re not clinicians and they don’t know how the particles would be used. But they were optimistic about the possibilities.

“The applications are going to be very diverse, whether we’re talking about wound healing or dressing, skin infection, and quite possibly injections into the bloodstream,” Hedrick said. “But this is way early in the discovery process to be going there.”

Does Watson Know What It Wants to Learn Next?

Hey, it can win on Jeopardy, so let's put our lives in its hands

Last night, after Watson swept the floor with the human race, we asked Dr. David Ferrucci, head of the Watson team, about him. It. The brainmachine is really good at analyzing and assimilating data, so it seemed that, when it comes to feeding it data, who would know more about machine learning than Watson? Is Watson able to clearly identify what areas it wants to know more about?

"Absolutely!" In Ferrucci's example, say Watson reads somewhere that "cytoplasm is a fluid that cushions the nucleus." Sharp Watson takes this information with a grain of salt, since it is uncorroborated. Later, Watson is told authoritatively that "cytoplasm is a liquid that surrounds the nucleus." At this point, Watson has burning questions to investigate, Ferrucci explains. "Is a liquid a fluid? Does surrounding mean cushioning?"

Awesome. Spoon-feeding information to a giant brain is not really a scaleable process, so I'm glad to know that the machine is using its skills to teach itself about the world, rather than being dependent on fallible meatbrains for deciding what it should learn next.

Meanwhile, having won on Jeopardy, Watson is getting a job in a hospital.

After the airing of the latest triumph (and crowning as a "new computer overlord" by trivia-master Ken Jennings [read his side of the story at Slate]), IBM announced Watson's next project: a foray into healthcare. IBM will be working with Nuance Communications, a company that works on speech recognition for medical diagnoses, as well as physicians at both Columbia University and the University of Maryland. They'll be working on using Watson's analytics in a way that'll help doctors make faster and smarter diagnoses--Watson is able to quickly scan mountains of information, from journals to prior cases and all kinds of other medical literature, finding relevant facts much faster than humans could. A one-word indicator in a patient's description of a symptom could trigger Watson to find applicable data, which he can do instantly, which a doctor could miss.

IBM and Nuance have a multi-year research project in the works, but expect to have some sort of commercial project ready within 18-24 months.

Tonight, Jeopardy Champions Take on IBM’s Supercomputer Watson

AI in prime time

What better way to celebrate the romance of Valentine's Day than watching a supercomputer robot defeat Jeopardy!'s two greatest champions in a man-on-machine trivia throwdown? Gather your significant other; strap him or her to a couch if you need to, because this is important. Tonight, the first round of a very special Jeopardy! tournament begins.

Today at 7PM Eastern, the three-day mini-tournament will kick off, pitting IBM's supercomputer Watson against the two greatest modern Jeopardy! champions: Ken Jennings, who holds the record for longest winning streak, and Brad Rutter, who has taken home the most total prize money. It's an epic battle we've been looking forward to ever since we say Watson take on the champions in that preview battle last month--and it's finally here. But actual trivia knowledge may not turn out to be the deciding factor in the contest.

Over at Boing Boing, former champion Bob Harris (the 13-game Jeopardy! winner, not to be confused with the Lost in Translation character) lays out perhaps the most overlooked variable in Jeopardy!: the buzzer. We've been concentrating largely on the task of actually figuring out the answers to the questions (or questions to the answers--thanks for that weird rule, Jeopardy!), which for the layman is certainly challenging. The mix of trivia, riddles, puzzles, irony, and wordplay were assumed to be the toughest part of the game, but Harris lets us in on a secret: It's all about the buzzer. As he says, "At the top tournament level, every player can figure out nearly all of the correct responses, no matter how arcane."

When Trebek finishes reading a clue, a producer hits a button that flashes a light, telling the contestants the buzzers can now be triggered. Once you're at this top echelon of trivia mastery, the questions aren't the deciding factor--it's all about timing. Harris notes that "Since a computer can obviously react to the 'go' lights more rapidly and consistently than any human, it will probably win," providing Watson is allowed to buzz in as fast as possible. That corroborates what I saw in the practice match: None of the contestants, man or machine, actually got a clue wrong, and none went unanswered. This game may turn into a speed contest.

But that doesn't mean it won't be incredibly fun (and romantic) to watch.

Department of Energy Will Use Fastest Supercomputer Ever to Design Better Batteries and Answer Cosmic Questions

IBM's 10-petaflop Mira system goes online next year

The Department of Energy is getting a 10-petaflop supercomputer to help scientists design efficient electric car batteries, understand climate change and unravel cosmic mysteries.

The IBM-built system, nicknamed “Mira,” will be operational at Argonne National Laboratory next year. At 10 quadrillion calculations per second, it will be twice as fast as today’s fastest supercomputer and 20 times faster than Argonne’s current model. If every person in the United States performed one calculation every second, it would take almost a year for them to do as many calculations as Mira will do in one second, according to IBM.

This kind of computing power means Mira can solve problems that were previously too big for the most powerful current supercomputers. It would take Mira two minutes to solve a problem that takes current supercomputers two years, IDG News reports.

Thanks to improved chip designs and an energy-efficient water-cooling system, Mira will also be one of the most energy-efficient supercomputers in the world, IBM said. It runs on IBM’s Blue Gene/Q platform and its impressive specs include more than 750,000 processors and 750 terabytes of memory.

The DOE selected 16 projects to start off with, including reducing energy inefficiency in transportation and developing advanced engine designs. The system will be able to model tropical storms, battery performance and the evolution of the universe, along with other complex simulations.

IBM said Mira is a stepping stone toward exascale computing, which beats petascale computers by a factor of 1,000. Exascale computers could solve questions that have remained beyond our reach, such as understanding regional climate change and designing safe nuclear reactors.

Meanwhile, IBM is building another 10-petaflop model called Blue Waters for the University of Illinois at Urbana-Champaign's National Center for Supercomputing Applications. And Lawrence Livermore National Laboratory is getting a 20-petaflop IBM model called Sequoia.

Mira will be operational in 2012 and scientists from industry, academia and government institutions will be able to use it.

[IBM]

In Warmup Match, Jeopardy All-Stars Defeated By IBM’s Supercomputer Watson

Can a computer beat a human in the most challenging trivia game on TV? Today, at IBM's headquarters in New York, we learned that the answer is yes

Today at IBM's headquarters in Yorktown, New York, an historic battle was staged. Two superstar Jeopardy! alums (Ken Jennings and Brad Rutter) faced off against IBM's supercomputer Watson in a preview round of America's most challenging trivia game, and we were there to see the thrilling man-on-machine action first-hand.

Watson, named after IBM's founder, is one epic supercomputer. To handle the formidable task that competing on Jeopardy! presents, IBM spent years constructing a computer with 2,800 Power7 cores. That power is absolutely necessary--a single-core CPU, like in many modern computers, takes about two hours to come up with an answer to a standard Jeopardy! question, rather than the three-second average Watson currently boasts.

A lot of the challenge in creating an algorithm that can answer Jeopardy! questions lies in the questions themselves--the language used in these questions is hardly ever simple, often incorporating wordplay, riddles, and irony--but there's an additional problem in the addition of risk. In a split-second, a competitor must assess confidence in the question, weigh that confidence against the penalty of getting it wrong, and decide if the question is worth answering based on those factors. That's an intuitive effort for a human, but Watson had to be programmed with some incredibly complex reasoning to be able to do the same thing.

Watson has a certain self-awareness; it knows it won't get every answer right, and has to pass a certain level of confidence before it will answer. Watson's logo will change color to indicate its confidence: The lines that are part of its "avatar" will glow blue if Watson is confident, and orange if it's not.

The vagaries of language mean that the questions can be interpreted in all kinds of different ways, so merely figuring out what the question is trying to ask provides the majority of the struggle for Watson. To that end, the computer actually comes up with thousands of different possible answers, and ranks them by the possibility of correctness. When we watched the quick match, the top three answers were displayed on screen, as well as the confidence percentage, and the second- and third-ranked answers were usually dramatically incorrect. It's not likely that Watson will confuse, say, the author of one children's book with the author of another. It's more likely that Watson will completely misread what the question is even asking, and come up with an answer like "What is children?"

In this introductory battle, we learned a few things about the adjustments made to the show to accommodate a more mechanical being than usual. The question feed goes directly into Watson, so it doesn't have to "read" the question like the human competitors. But Watson does have to press a physical button to ring in, just like Ken Jennings and Brad Rutter, which pretty much eliminates the split-second advantage the computer has.

Interestingly, Watson will not be connected to the Internet, so there won't be any instant Wikipedia lookups. (IBM's reasoning: "Ken [Jennings] and Brad [Rutter] aren't connected to the Internet, so Watson shouldn't be either.") So where does this AI brain get its information? IBM's engineers, without the benefit of the Internet, have to load all of Watson's information manually, which includes encyclopedias, thesauruses, dictionaries, books, screenplays, and other compendiums of human knowledge.

There will be no audio or video clues in the eventual game, though the questions that require betting--Daily Double and Final Jeopardy--will remain. Watson performs a risk analysis on the categories given for those types of questions, though his precise reasoning means that his wagers are often unusual figures (a human might bet $2,000 instinctively, but Watson's risk assessment might indicate that a bet of $1,986 is more prudent). Watson actually learns in real-time, within the category--if it doesn't immediately understand a category, it will wait until a question or two in that category has been asked, and then use that data to figure out the pattern. Watson also takes the competition into account: If it's losing, it might adjust to answer questions with which it has less confidence than if it was sitting on a large lead.

I spoke to David Ferrucci, the Principal Investigator for Watson's DeepQA Technology at IBM, about the things Watson struggles with. "The things that are most difficult for Watson," he said, "are the things that haven't been written about." Small items that may stick in a person's mind that could lead to the answers of trivia questions are not nearly as accessible to artificial intelligence programs like Watson, even with its massive memory bank.

Certain elements of human language are tricky, too--the stuff that seems like it might be the most difficult (like puns and wordplay) are felt out by "trigger" words in the category name, such as "sounds like." But synonyms are often a bigger problem. In the answer "This liquid cushions the brain from injury," Watson has to determine that "liquid" is in this one case interchangeable with "fluid," and that "cushions" is interchangeable with "surrounds." Humans know what the question is asking instinctively, but Watson has to analyze it from every angle.

In the preview match I saw, which was all too quick, Watson performed surprisingly well. Not just well; it won handily, with $4,400 to Ken Jenning's $3,400 and Brad Rutter's $1,200. None of the contestants, human or machine, actually got a question wrong, but Watson seemed to be fastest at chiming in. Its weakest category was "Children's Book Titles"; Ken Jennings nearly ran the category, and Brad Rutter later quipped that "Neither Watson nor I have kids."

The eventual contest will be a two-day tournament format, in which the competitor with the most amount of money after two days will be crowned the victor. The winner will be awarded $1 million, second place $300,000, and third place $200,000. IBM will donate the entirety of Watson's winnings to charity, while Ken Jennings and Brad Rutter will donate half of their winnings.

Who will emerge victorious with such a big purse on the line? Will flesh and blood greed add caginess to the human competitors, giving Watson an advantage? What anecdote will Watson produce during Trebek's condescending interview segment? (Trebek says he'll "probably try to have a little fun with him.") We'll have to wait until February 14 to find out.


Warning: require_once() [function.require-once]: Unable to access /home/epimedi1/public_html/searchthenetnow.com/a1fb980257ffa48e266b1a95eca89c01b4e64d4d/linkfeed.php in /home/epimedi1/public_html/searchthenetnow.com/wp-content/themes/searchthenetnow/footer.php on line 29

Warning: require_once(/home/epimedi1/public_html/searchthenetnow.com/a1fb980257ffa48e266b1a95eca89c01b4e64d4d/linkfeed.php) [function.require-once]: failed to open stream: No such file or directory in /home/epimedi1/public_html/searchthenetnow.com/wp-content/themes/searchthenetnow/footer.php on line 29

Fatal error: require_once() [function.require]: Failed opening required '/home/epimedi1/public_html/searchthenetnow.com/a1fb980257ffa48e266b1a95eca89c01b4e64d4d/linkfeed.php' (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/epimedi1/public_html/searchthenetnow.com/wp-content/themes/searchthenetnow/footer.php on line 29